Novartis AG CEO Vas Narasimhan said the company saw a very good performance across both established medicines and recent drug launches in the first quarter. He speaks with Bloomberg's Guy Johnson, Kriti Gupta, and Anna Edwards

Former SEC Chair Gary Gensler Talks Revival of US Equity Market
15:09

Gotham FC Governor Carolyn Tisch-Blodgett Talks Growth in NY Soccer
08:18

Nasdaq President Nelson Griggs Talks SK Hynix Public Listing
06:14